Investeringsoversigt

597 investments

Titel Sort descending	Periode	Program
HHC Medical, Improving chemotherapy - Tekniske landevinding ved CTO fuld tid	2021 - 2022	Innofounder
HHC Medical, Improving chemotherapy - Tekniske landevinding ved CTO fuld tid Period 2021 - 2022 Region Region Hovedstaden Program Innofounder Area Biotek, Medico og Sundhed Investment Percentage 100 Invested 460.000 Budget 460.000 Partners HHC Medical ApS People HHC Medical ApS Read more about the project
High content screening platform for industrial enzyme engineering	2019 - 2022	Industrial Researcher
High content screening platform for industrial enzyme engineering Period 2019 - 2022 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 48.09 Invested 1.2 mill. Budget 2.6 mill. Partners University of Copenhagen, NOVOZYMES A/S People NOVOZYMES A/S Read more about the project
Honeybee venom allergy: Drug discovery and improvement of existing products	2020 - 2023	Industrial Researcher
Honeybee venom allergy: Drug discovery and improvement of existing products Period 2020 - 2023 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 52.6 Invested 1.1 mill. Budget 2.0 mill. Partners Aarhus University, ALK-ABELLO A/S People ALK-ABELLO A/S Read more about the project
Hospital@Night H@N	2019 - 2022	Grand Solutions
Hospital@Night H@N Period 2019 - 2022 Region Region Midtjylland Program Grand Solutions Area Biotek, Medico og Sundhed Investment Percentage 67.51 Invested 19.3 mill. Budget 28.5 mill. Partners Aarhus University, Systematic A/S, Aalborg Universitetshospital, Aarhus University Hospital People SYSTEMATIC A/S Read more about the project
Human clinical proof-of-concept for a novel concept for treating atrial fibrillation (AF)	2019 - 2020	Innobooster
Human clinical proof-of-concept for a novel concept for treating atrial fibrillation (AF) Period 2019 - 2020 Region Region Hovedstaden Program Innobooster Area Biotek, Medico og Sundhed Investment Percentage 25.67 Invested 5.0 mill. Budget 19.3 mill. Partners Acesion Pharma ApS People ACESION PHARMA ApS Read more about the project
Human iPSC based in vitro and in vivo models to qualify how drug targets in inflammatory astrocytes and microglia affect neuronal pathology development	2019 - 2022	Industrial Researcher
Human iPSC based in vitro and in vivo models to qualify how drug targets in inflammatory astrocytes and microglia affect neuronal pathology development Period 2019 - 2022 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 41.94 Invested 1.2 mill. Budget 3.0 mill. Partners H LUNDBECK A/S People H LUNDBECK A/S Read more about the project
Human Milk Oligosaccharides EXpanded PORTfolio by novel enzymatic routes HMO-EXPORT	2019 - 2022	Grand Solutions
Human Milk Oligosaccharides EXpanded PORTfolio by novel enzymatic routes HMO-EXPORT Period 2019 - 2022 Region Region Hovedstaden Program Grand Solutions Area Biotek, Medico og Sundhed Investment Percentage 63.12 Invested 7.1 mill. Budget 11.3 mill. Partners Glycom A/S, Technical University of Denmark People GLYCOM A/S Read more about the project
Hyalink™ 3D - superior & ready-to-use hyaluronic acid-based 3D cell cultures	2018 - 2019	Innobooster
Hyalink™ 3D - superior & ready-to-use hyaluronic acid-based 3D cell cultures Period 2018 - 2019 Region Region Hovedstaden Program Innobooster Area Biotek, Medico og Sundhed Investment Percentage 33 Invested 497.063 Budget 1.5 mill. Partners Hyamedix IVS People Hyamedix ApS Read more about the project
HyperPET/MR: a new concept of hybrid molecular imaging in cancer using simultaneous PET and 13C-hyperpolarized MRSI	2015 - 2018	Grand Solutions
HyperPET/MR: a new concept of hybrid molecular imaging in cancer using simultaneous PET and 13C-hyperpolarized MRSI Period 2015 - 2018 Region Program Grand Solutions Area Biotek, Medico og Sundhed Investment Percentage 66.66 Invested 14.1 mill. Budget 21.1 mill. Partners Rigshospitalet, University of Copenhagen, Technical University of Denmark, GE Healthcare Denmark A/S, University of Cambridge, Stanford University, Curasigtht ApS People Aktiv Read more about the project
I-SENSE (Implementing Social distancing in dENmark and SwEden) IMPLEMENTING SOCIAL DISTANCING POLICY MEASURES IN THE BATTLE AGAINST THE CORONAVIRUS – A COMPARATIVE STUDY OF DENMARK AND SWEDEN	2020 - 2022	Grand Solutions
I-SENSE (Implementing Social distancing in dENmark and SwEden) IMPLEMENTING SOCIAL DISTANCING POLICY MEASURES IN THE BATTLE AGAINST THE CORONAVIRUS – A COMPARATIVE STUDY OF DENMARK AND SWEDEN Period 2020 - 2022 Region Region Hovedstaden Program Grand Solutions Area Biotek, Medico og Sundhed Investment Percentage 89.41 Invested 4.1 mill. Budget 4.6 mill. Partners Hvidovre Hospital, The University of Southern Denmark, Denmark., Linköping University People Region Hovedstaden Read more about the project
iBiocover-Bioteknologisk reduktion af metanudslip fra lossepladser	2019 - 2020	Innobooster
iBiocover-Bioteknologisk reduktion af metanudslip fra lossepladser Period 2019 - 2020 Region Region Hovedstaden Program Innobooster Area Biotek, Medico og Sundhed Investment Percentage 33 Invested 173.250 Budget 525.000 Partners Danish Waste Solutions ApS People DANISH WASTE SOLUTIONS ApS Read more about the project
Identification and characterization of peripheral hypocretin as a potential drug target in metabolic diseases	2018 - 2022	Industrial Researcher
Identification and characterization of peripheral hypocretin as a potential drug target in metabolic diseases Period 2018 - 2022 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 50.27 Invested 1.1 mill. Budget 2.1 mill. Partners University of Copenhagen, Gubra Aps People Gubra Aps Read more about the project
Identification and clinical validation of a predictive biomarker profile for taxane sensitivity in prostate cancer	2016 - 2019	Industrial Researcher
Identification and clinical validation of a predictive biomarker profile for taxane sensitivity in prostate cancer Period 2016 - 2019 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 66.3 Invested 1.0 mill. Budget 1.5 mill. Partners Allarity Therapeutics A/S People Allarity Therapeutics A/S Read more about the project
Identification and validation of fibrosis targets in non-alcoholic steatohepatitis	2019 - 2022	Industrial Researcher
Identification and validation of fibrosis targets in non-alcoholic steatohepatitis Period 2019 - 2022 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 56.57 Invested 1.1 mill. Budget 1.9 mill. Partners University of Copenhagen, Gubra People Gubra Read more about the project
Identification of Meteorin and Cometin receptors	2020 - 2021	Industrial Researcher
Identification of Meteorin and Cometin receptors Period 2020 - 2021 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 38.76 Invested 414.000 Budget 1.1 mill. Partners University of Copenhagen, Hoba Therapeutics ApS People Hoba Therapeutics ApS Read more about the project